Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD effects on cardiac function in children with DS and LGS
NCT02815540Phase 2Terminated
- Sponsor
- Gillette Children's Specialty Healthcare
- Start
- Feb 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Dravet syndrome, Lennox-Gastaut syndrome (LGS), sponsored by Gillette Children's Specialty Healthcare. Started Feb 2017; status: terminated.
02
Drugs
cannabidiol
03
Conditions
Dravet syndromeLennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT02815540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02815540.